Study finds need for better inclusion of patients from racial minority groups in radiation therapy trials

Cleansweep Live Auction Thursday Jan. 21th 10AM EST - Pre-Bid Now
California Auction Event Closing Jan. 26th - Bid Now

Study finds need for better inclusion of patients from racial minority groups in radiation therapy trials

Press releases may be edited for formatting or style | October 28, 2020 Rad Oncology

While etiologies behind the disparities were beyond the scope of the current study, ASTRO's Committee on Health Equity, Diversity and Inclusion (CHEDI) outlined several barriers to trial participation in a 2019 blog post. Structural racism, distrust of medical providers, hidden costs associated with trial participation and a lack of community outreach by researchers all consistently limit inclusion of patients from underrepresented minority groups in cancer clinical trials. These obstacles call for solutions including improved diversity in the physician workforce, greater community involvement, such as partnering with community cancer centers, and more recruitment and support programs tailored to specific cultural backgrounds.

"Clinical trials are the mainstay in the development and validation of new cancer therapies and treatment options," wrote Fumiko Chino, MD, in the post. "As racial/ethnic minorities carry some of the highest cancer burdens in the United States, equitable participation in clinical trials becomes an important tool in the fight against health care disparities."

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.


Characterization of Underrepresented Populations in Modern Era Radiation Therapy Clinical Trials (Abstract 204)
Visit our press kit to hear this study presented in a news briefing.


About ASTRO
The American Society for Radiation Oncology (ASTRO) is the world’s largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute.

Back to HCB News

You Must Be Logged In To Post A Comment